Hyperbaric oxygen therapy and neurological disease.

摘要

We read this recent editorial with concern. While agreeing it is entirely appropriate that the UHMS actively support the investigation of HBO2 therapy (HBO2T) for novel applications, we cannot let the main implications of the editorial pass without remark.The editorial begins with some pertinent issues about the philosophy and practice of research funding in the United States, which, for the clinical scientist, can be one of the most time-consuming and challenging aspects of modern academic medicine.